When a dying patient is asked to participate in a double-blind, placebo-controlled clinical trial on symptom control : the decision-making process and experiences of relatives

Article indépendant

VAN ESCH, Harriëtte J. | STOPPELENBURG, Arianne | VAN ZUYLEN, Lia | VAN DER RIJT, Carin Cd | VAN DER HEIDE, Agnes

Background: Placebo-controlled trials can provide evidence to inform end-of-life care, but it is contested whether asking dying patients to participate in such trials is morally justifiable. To investigate the experiences of these patients is even more complex. Therefore, proxy assessments by relatives can be a good alternative. Aim: To explore the experience of participating in a placebo-controlled trial at the end of life from the perspective of bereaved relatives. Design: Mixed-method study, including questionnaires and interviews. Setting/Participants: The SILENCE study was a randomized, double-blind, placebo-controlled trial on the efficacy of scopolamine butylbromide to prevent death rattle. The study was performed in six inpatient hospice facilities. Patients were asked to participate at admission in the hospice. Three months after the death of the patient, bereaved relatives were invited to fill in a questionnaire and to participate in an interview. One hundred four questionnaires were completed and 17 relatives were interviewed. Results: Fourteen percent of the relatives participating in the questionnaire study considered the participation of their loved one in research a bit burdensome and 10% considered it a bit stressful. Seventeen percent thought that it was a bit burdensome for the patient. Eighty-three percent considered participation in this type of research (very) valuable. The in-depth interviews showed that patients and relatives jointly decided about participation in this double-blind placebo-controlled medication trial. Relatives generally respected and felt proud about patients' decision to participate. Conclusion: The large majority of bereaved relatives experienced the participation of their dying love one in this RCT as acceptable and valuable.

http://dx.doi.org/10.1177/02692163221127557

Voir la revue «PALLIATIVE MEDICINE, 36»

Autres numéros de la revue «PALLIATIVE MEDICINE»

Consulter en ligne

Suggestions

Du même auteur

When a dying patient is asked to participate ...

Article indépendant | VAN ESCH, Harriëtte J. | PALLIATIVE MEDICINE | n°10 | vol.36

Background: Placebo-controlled trials can provide evidence to inform end-of-life care, but it is contested whether asking dying patients to participate in such trials is morally justifiable. To investigate the experiences of these...

Scopolaminebutyl given prophylactically for d...

Article | VAN ESCH, Harriëtte J. | BMC palliative care | n°1 | vol.17

BACKGROUND: Death rattle (DR), caused by mucus in the respiratory tract, occurs in about half of patients who are in the dying phase. Relatives often experience DR as distressing. Anticholinergics are recommended to treat DR, alth...

Scopolaminebutyl given prophylactically for d...

Article indépendant | VAN ESCH, Harriëtte J. | BMC palliative care | n°1 | vol.17

BACKGROUND: Death rattle (DR), caused by mucus in the respiratory tract, occurs in about half of patients who are in the dying phase. Relatives often experience DR as distressing. Anticholinergics are recommended to treat DR, alth...

De la même série

Posttraumatic growth in palliative care setti...

Article indépendant | AUSTIN, Philip D. | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: Posttraumatic growth refers to positive psychological change following trauma. However, there is a need to better understand the experience of posttraumatic growth in the palliative care setting as well as the availabi...

Long-term bereavement outcomes in family memb...

Article indépendant | LAPENSKIE, Julie | PALLIATIVE MEDICINE | n°2 | vol.38

Background: Severe grief is highly distressing and prevalent up to 1 year post-death among people bereaved during the first wave of COVID-19, but no study has assessed changes in grief severity beyond this timeframe. Aim: Understa...

Understanding the extent to which PROMs and P...

Article indépendant | HOWARD, Faith D. | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: Older people with severe frailty are nearing the end of life but their needs are often unknown and unmet. Systematic ways to capture and measure the needs of this group are required. Patient reported Outcome Measures (...

The perspectives of people with dementia and ...

Article indépendant | MONNET, Fanny | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: Advance care planning has been defined in an international consensus paper, supported by the European Association for Palliative Care. There are concerns that this definition may not apply to dementia. Moreover, it is ...

Revised European Association for Palliative C...

Article indépendant | SURGES, Séverine M. | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: The European Association for Palliative Care (EAPC) acknowledges palliative sedation as an important, broadly accepted intervention for patients with life-limiting disease experiencing refractory symptoms. The EAPC the...

Chargement des enrichissements...